TABLE 3.
W (n = 14) | W-EX (n = 13) | SHR (n = 18) | SHR-EX (n = 17) | |
CSA (mm2) | 1.26 ± 0.15 | 1.24 ± 0.15 | 1.33 ± 0.17 | 1.24 ± 0.19 |
DT (g/mm2) | 5.02 ± 1.41 | 4.84 ± 1.10 | 5.77 ± 1.32 | 6.35 ± 0.82# |
RT (g/mm2) | 0.57 ± 0.17 | 0.52 ± 0.09 | 0.78 ± 0.15* | 0.79 ± 0.19# |
+dT/dt (g/mm2/s) | 53.3 ± 16.8 | 50.4 ± 11.5 | 52.2 ± 12.8 | 63.4 ± 9.78#§ |
–dT/dt (g/mm2/s) | 20.2 ± 4.74 | 19.6 ± 3.49 | 23.2 ± 4.41* | 24.7 ± 3.30# |
Data as mean ± standard deviation. W, Wistar rats; W-EX, exercised Wistar rats; SHR, spontaneously hypertensive rats; SHR-EX, exercised SHR; CSA, papillary muscle cross-sectional area; DT, developed tension; RT, resting tension; +dT/dt, maximum rate of tension development; –dT/dt, maximum rate of tension decrease. ANOVA for a 2 × 2 factorial design and Tukey; *p < 0.05 vs. W; #p < 0.05 vs. W-EX; §p < 0.05 vs. SHR.